• Profile
Close

Overexpressed PKMYT1 promotes tumor progression and associates with poor survival in esophageal squamous cell carcinoma

Cancer Management and Research Aug 23, 2019

Zhang Q, Zhao X, Zhang C, et al. - Researchers focused on protein kinase, membrane associated tyrosine/threonine (PKMYT1) expression as well as its role in esophageal squamous cell carcinoma (ESCC). They found that tumor tissues and ESCC cell lines exhibited upregulation of PKMYT1. A correlation was found between higher expression of PKMYT1 and poorer overall survival in ESCC patients. As a result of knocking down PKMYT1 in ESCC cell lines KYSE70 and KYSE450, more cells skipped G2/M checkpoint to complete mitosis, leading to cell apoptosis promotion, cell proliferation inhibition, and prevention of the EMT phenotype in vitro. Meantime, AKT/mTOR signaling pathway suppression by down-regulated PKMYT1 in ESCC cells was also noted. Overall, an important role of PKMYT1 in ESCC progression was highlighted and it might represent a new target in the treatment of ESCC.
Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay